Excellent quarter from AbbVie, but market still skeptic about pipeline

US-based AbbVie on Friday reported new positive quarter results to the financial community. The group’s sales were up 18.5% and EBIT was up 31%, reaching $2.7bn. Sales from Humira, the best-sold drug in the world, keep increasing, indeed revenues increased by 9.5% in the third quarter, despite the treatment’s patent has expired.